Norephedrine-Expectorant Nasal Decongestant Solution from United States
A bulk solution blending norephedrine salts with phenylephrine and mucolytics for sinus congestion relief in clinical settings. It is a mixed therapeutic preparation, not for retail sale, and contains norephedrine or its salts, qualifying under the tariff item.
Duty Rate — United States → Canada
0%
Import Tips
• Ensure the solution is not in measured doses or retail packings; otherwise it may be classified under 3004
• Provide the CBSA with a certificate of analysis showing norephedrine content
• Confirm that phenylephrine and mucolytics are permitted in combination under Canadian drug regulations